JP2012511571A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012511571A5 JP2012511571A5 JP2011540664A JP2011540664A JP2012511571A5 JP 2012511571 A5 JP2012511571 A5 JP 2012511571A5 JP 2011540664 A JP2011540664 A JP 2011540664A JP 2011540664 A JP2011540664 A JP 2011540664A JP 2012511571 A5 JP2012511571 A5 JP 2012511571A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- scale
- ray diffraction
- salt according
- peaks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 16
- 238000002441 X-ray diffraction Methods 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 230000002062 proliferating effect Effects 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- -1 2-Pyrrolidin-1-yl-ethoxy Chemical group 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12166808P | 2008-12-11 | 2008-12-11 | |
| US61/121,668 | 2008-12-11 | ||
| PCT/SG2009/000473 WO2010068181A1 (en) | 2008-12-11 | 2009-12-09 | 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27)j16,21,23-decaene citrate salt |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012511571A JP2012511571A (ja) | 2012-05-24 |
| JP2012511571A5 true JP2012511571A5 (OSRAM) | 2013-01-24 |
| JP5669748B2 JP5669748B2 (ja) | 2015-02-12 |
Family
ID=41666397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011540664A Active JP5669748B2 (ja) | 2008-12-11 | 2009-12-09 | １１−（２−ピロリジン−１−イル−エトキシ）−１４，１９−ジオキサ−５，７，２６−トリアザ−テトラシクロ［１９．３．１．１（２，６）．１（８，１２）］ヘプタコサ−１（２５），２（２６），３，５，８，１０，１２（２７），１６，２１，２３−デカエンクエン酸塩 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US8980873B2 (OSRAM) |
| EP (1) | EP2376499B1 (OSRAM) |
| JP (1) | JP5669748B2 (OSRAM) |
| KR (1) | KR101729918B1 (OSRAM) |
| CN (1) | CN102282148B (OSRAM) |
| AR (2) | AR074724A1 (OSRAM) |
| AU (1) | AU2009325147B2 (OSRAM) |
| BR (1) | BRPI0922736B1 (OSRAM) |
| CA (1) | CA2746058C (OSRAM) |
| DK (1) | DK2376499T3 (OSRAM) |
| ES (1) | ES2536558T3 (OSRAM) |
| HR (1) | HRP20150428T1 (OSRAM) |
| IL (3) | IL213418A0 (OSRAM) |
| MX (1) | MX2011006206A (OSRAM) |
| MY (1) | MY160005A (OSRAM) |
| NZ (1) | NZ593223A (OSRAM) |
| PL (1) | PL2376499T3 (OSRAM) |
| PT (1) | PT2376499E (OSRAM) |
| RU (1) | RU2527970C2 (OSRAM) |
| SG (1) | SG171907A1 (OSRAM) |
| TW (1) | TWI449705B (OSRAM) |
| WO (1) | WO2010068181A1 (OSRAM) |
| ZA (1) | ZA201104032B (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2376499B1 (en) | 2008-12-11 | 2015-02-25 | Cti Biopharma Corp. | 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt |
| WO2010068182A1 (en) * | 2008-12-11 | 2010-06-17 | S*Bio Pte Ltd | 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene maleate salt |
| EP2837632B1 (en) | 2012-04-13 | 2016-05-18 | Lianyungang Jinkang Hexin Pharmaceutical Co. Ltd. | Derivatives of triazabicyclo[3.2.1]octane useful for the treatment of proliferative diseases |
| CN105061467B (zh) * | 2015-08-28 | 2017-08-25 | 苏州立新制药有限公司 | 一种帕克替尼的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5728536A (en) | 1993-07-29 | 1998-03-17 | St. Jude Children's Research Hospital | Jak kinases and regulation of Cytokine signal transduction |
| US6136595A (en) | 1993-07-29 | 2000-10-24 | St. Jude Children's Research Hospital | Jak kinases and regulations of cytokine signal transduction |
| UA73421C2 (en) * | 2001-05-14 | 2005-07-15 | Pfizer Prod Inc | Cytrate salt 5,8,14-triazatetracyclo[10.3.1.02,11.04,9] hexadeca-2(11),3,5,7,9-pentaene and a pharmaceutical composition based thereon |
| US6433018B1 (en) | 2001-08-31 | 2002-08-13 | The Research Foundation Of State University Of New York | Method for reducing hypertrophy and ischemia |
| DE60209929T2 (de) * | 2001-11-29 | 2006-11-16 | Pfizer Products Inc., Groton | Succinatsalze von 58;8;14-triatetracyclo[10.3.1.0 2,11 .0 4,9]-hexadeca-2,11,3,5,7,9,-pentaen und pharmazeutische zusammensetzungen |
| PT1951730E (pt) * | 2005-11-16 | 2010-08-27 | S Bio Pte Ltd | Derivados de pirimidina ligados a heteroalquilo |
| EP2376499B1 (en) | 2008-12-11 | 2015-02-25 | Cti Biopharma Corp. | 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt |
-
2009
- 2009-12-09 EP EP09788621.2A patent/EP2376499B1/en active Active
- 2009-12-09 KR KR1020117015738A patent/KR101729918B1/ko active Active
- 2009-12-09 ES ES09788621.2T patent/ES2536558T3/es active Active
- 2009-12-09 AU AU2009325147A patent/AU2009325147B2/en active Active
- 2009-12-09 MX MX2011006206A patent/MX2011006206A/es active IP Right Grant
- 2009-12-09 PL PL09788621T patent/PL2376499T3/pl unknown
- 2009-12-09 CA CA2746058A patent/CA2746058C/en active Active
- 2009-12-09 MY MYPI2011002647A patent/MY160005A/en unknown
- 2009-12-09 DK DK09788621T patent/DK2376499T3/en active
- 2009-12-09 HR HRP20150428TT patent/HRP20150428T1/hr unknown
- 2009-12-09 PT PT97886212T patent/PT2376499E/pt unknown
- 2009-12-09 SG SG2011040060A patent/SG171907A1/en unknown
- 2009-12-09 RU RU2011126173/04A patent/RU2527970C2/ru active
- 2009-12-09 BR BRPI0922736-9A patent/BRPI0922736B1/pt active IP Right Grant
- 2009-12-09 WO PCT/SG2009/000473 patent/WO2010068181A1/en not_active Ceased
- 2009-12-09 NZ NZ593223A patent/NZ593223A/xx unknown
- 2009-12-09 JP JP2011540664A patent/JP5669748B2/ja active Active
- 2009-12-09 US US13/133,297 patent/US8980873B2/en active Active
- 2009-12-09 CN CN200980150325.5A patent/CN102282148B/zh active Active
- 2009-12-11 AR ARP090104834A patent/AR074724A1/es not_active Application Discontinuation
- 2009-12-11 TW TW098142605A patent/TWI449705B/zh active
-
2011
- 2011-05-31 ZA ZA2011/04032A patent/ZA201104032B/en unknown
- 2011-06-06 IL IL213418A patent/IL213418A0/en unknown
-
2015
- 2015-02-13 US US14/621,726 patent/US9624242B2/en active Active
-
2017
- 2017-01-26 IL IL250310A patent/IL250310A0/en unknown
-
2019
- 2019-03-20 AR ARP190100701A patent/AR114133A2/es unknown
-
2021
- 2021-12-26 IL IL289379A patent/IL289379A/en unknown